NCT04507009

Brief Summary

The aim of this study is to investigate the efficacy of CGF and Ozone in the treatment of alveolitis and to develop a new treatment protocol that can enable a quick and effective solution of this clinical problem, which significantly affects patients' comfort of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2020

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

August 4, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 10, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

November 9, 2022

Status Verified

November 1, 2022

Enrollment Period

2 years

First QC Date

August 4, 2020

Last Update Submit

November 5, 2022

Conditions

Keywords

AlveolitisDry socketOzoneCGF

Outcome Measures

Primary Outcomes (1)

  • Change in post-operative pain assessed: visual analog (VAS) scale

    For the evaluation of the pain, the visual analog scale (VAS) will be used to express the absence of pain in the initial part on a straight line (0) and the end part to express the unbearable pain (10). 0 (no pain)--------------------------------------------------------------------------------10 (unbearable pain) Higher values of the scale represent worse outcome.

    6th and 24th hour, 2nd day, 3rd day, 4th day, 5th day, 6th day and 7th day

Secondary Outcomes (3)

  • Granulation tissue health

    postoperative 1st, 3rd, 7th days

  • Inflamation severity

    postoperative 1st, 3rd, 7th days

  • Change in the quality of postoperative life after the procedures performed

    postoperative 7th day

Other Outcomes (1)

  • Oral hygiene degree

    Evaluation of the oral hygiene before operation

Study Arms (3)

Control

ACTIVE COMPARATOR

Traditional treatment group which alvogyl applied to the socket after irrigation

Other: Traditional treatment

Ozone

EXPERIMENTAL

Ozone group which Ozone (O3) applied after irrigation of the socket

Device: Ozone

CGF +Ozone

EXPERIMENTAL

CGF + Ozone group which concentrated growth factor (CGF) after Ozone (O3) applied followed by irrigation of the socket.

Device: OzoneOther: CGF

Interventions

OzoneDEVICE

topical gaseous ozone application

CGF +OzoneOzone
CGFOTHER

concentrated growth factor (CGF) application

CGF +Ozone

Alvogyl application

Control

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who have one or more of the following in addition to severe pain, which occur within and around the socket 1-3 days after extraction and do not decrease with pain killers;
  • With a partially or completely disintegrated blood clot in the socket
  • With exposed bone that gives a dark gray appearance
  • With bad odor

You may not qualify if:

  • Who does not want to be volunteer for the study,
  • Smokers,
  • During pregnancy or lactation,
  • Has a chronic systemic disorder that will affect recovery,
  • Has hematological disorder
  • Cooperation cannot be established,
  • Previously received radiotherapy or chemotherapy,
  • Patients using oral contraceptives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ordu University

Ordu, 52200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Dry Socket

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Study Officials

  • Damla Torul, DDS PhD

    Ordu University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 4, 2020

First Posted

August 10, 2020

Study Start

August 1, 2020

Primary Completion

August 1, 2022

Study Completion

October 1, 2022

Last Updated

November 9, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

IPD can share with other researchers on demand

Locations